1. Koutras DA. Iodine metabolism in endemic goitre. Ann Clin Res 1972;4:55–63 [review].
2. Lee K, Bradley R, Dwyer J, Lee S. Too much versus too little: The implications of current iodine intake in the United States. Nutr Rev 1999;57:177–81 [review].
3. Cotran RS, Kumar V, Robbins SL. Robbins Pathologic Basis of Disease, 4th edition. Philadelphia: WB Saunders Co, 1989, 1227–8.
4. Gaitan E. Goitrogens in food and water. Annu Rev Nutr 1990;10:21–39 [review].
5. Wilson JD, Foster DW, Kronenberg HM, Larsen PR. Williams Textbook of Endocrinology, 9th edition. Philadelphia: WB Saunders Co, 1998, 469.
6. Vermiglio F, Lo Presti VP, Moleti M, et al. Attention deficit and hyperactivity disorders in the offspring of mothers exposed to mild-moderate iodine deficiency: a possible novel iodine deficiency disorder in developed countries. J Clin Endocrinol Metab 2004;89:6054–60.
7. Thilly CH, Swennen B, Bourdoux P, et al. The epidemiology of iodine-deficiency disorders in relation to goitrogenic factors and thyroid-stimulating-hormone regulation. Am J Clin Nutr l 1993;57(2 Suppl):267S–70S.
8. Delange F. Risks and benefits of iodine supplementation. Lancet 1998;351:923–4.
9. Contempre B, Dumont JE, Ngo B, et al. Effect of selenium supplementation in hypothyroid subjects of an iodine and selenium deficient area: the possible danger of indiscriminate supplementation of iodine-deficient subjects with selenium. J Clin Endocrinol Metab 1991;73:213–5.
10. Chow CC, Phillips DIW, Lazarus JH, Parkes AB. Effect of low dose iodide supplementation on thyroid function in potentially susceptible subjects: are dietary iodide levels in Britain acceptable? Clin Endocrinol 1991;34:413–6.
11. Stewart JC, Vidor GI. Thyrotoxicosis induced by iodine contamination of food: a common unrecognized condition? Br Med J 1976;1:372–5.
12. Krouse TB, Eskin BA, Mobini J. Age-related changes resembling fibrocystic disease in iodine-blocked rat breasts. Arch Pathol Lab Med 1979;103:631–4.
13. Ghent WR, Eskin BA, Low DA, Hill L. Iodine replacement in fibrocystic disease of the breast. Can J Surg 1993;36:453–60.
14. Hollowell JG, Staehling NW, Hannon WH, et al. Iodine nutrition in the United States. Trends and public health implications: iodine excretion data from National Health and Nutrition Examination Surveys I and III (1971–1974 and 1988–1994). J Clin Endocrinol Metab 1998;83:3104–8.
15. Zimmermann M, Adou P, Torresani T, et al. Persistence of goiter despite oral iodine supplementation in goitrous children with iron deficiency anemia in Cote d’Ivoire. Am J Clin Nutr 2000;71:88–93.
16. Zimmermann M, Adou P, Torresani T, et al. Iron supplementation in goitrous, iron-deficient children improves their response to oral iodized oil. Eur J Endocrinol 2000;142:217–23.
17. Mu L, Derun L, Chengyi Q, et al. Endemic goiter in central China caused by excessive iodine intake. Lancet 1987;2:257–9.
18. Heymann WR. Potassium iodide and the Wolff-Chaikoff effect: Relevance for the dermatologist. J Am Acad Dermatol. 2000 Mar;42:490–2.
19. Pennington JA. A review of iodine toxicity reports. J Am Diet Assoc 1990;90:1571–81.
20. Williams ED, Doniach I, Bjarnason O, et al. Thyroid cancer in an iodide rich area. Cancer 1977;39:215–22.
21. Kim JY, Kim KR. Dietary iodine intake and urinary iodine excretion in patients with thyroid diseases. Yonsei Med J. 2000;41:22–8.
22. Harach HR, Williams ED. Thyroid cancer and thyroiditis in the goitrous region of Salta, Argentina, before and after iodine prophylaxis. Clin Endocrinol (Oxf) 1995;43:701–6.
23. Harach HR, Escalante DA, Onativia A, et al. Thyroid carcinoma and thyroiditis in an endemic goitre region before and after iodine prophylaxis. Acta Endocrinol (Copenh) 1985;108:55–60.
24. Papanastasiou L, Alevizaki M, Piperingos G, et al. The effect of iodine administration on the development of thyroid autoimmunity in patients with nontoxic goiter. Thyroid 2000;10:493–7.
